6 patents
Utility
Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic
19 Dec 23
This invention provides a method for treating a subject afflicted with cancer, comprising administering to the subject (i) a BCL-2 inhibitor in conjunction with (ii) an alpha-emitting isotope-labeled agent that targets cancer cells in the subject, wherein the amounts of the BCL-2 inhibitor and labeled agent, when administered in conjunction with one another, are therapeutically effective.
Dragan Cicic
Filed: 16 May 22
Utility
Stabilized radiolabeled anti-CD45 immunoglobulin compositions
9 Aug 22
Compositions and methods are described for stabilizing a radio-iodinated monoclonal IgG antibody for up to 17 days against radiolytic decomposition.
Kaushik J. Dave, Shubh D. Sharma
Filed: 11 Mar 19
Utility
Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic
21 Jun 22
This invention provides a method for treating a subject afflicted with cancer, comprising administering to the subject (i) a BCL-2 inhibitor in conjunction with (ii) an alpha-emitting isotope-labeled agent that targets cancer cells in the subject, wherein the amounts of the BCL-2 inhibitor and labeled agent, when administered in conjunction with one another, are therapeutically effective.
Dragan Cicic
Filed: 26 Apr 18
Utility
Low dose antibody-based methods for treating hematologic malignancies
5 Apr 22
This invention provides a method for treating a subject afflicted with a hematologic malignancy comprising administering to the subject an agent targeting a hematologic malignancy-associated antigen, wherein the subject has a low peripheral cancerous cell burden.
Dragan Cicic
Filed: 25 May 17
Utility
Stabilized radio-labeled anti-CD45 immunoglobulin compositions
8 Feb 22
Compositions and methods are described for stabilizing a radio-iodinated monoclonal IgG antibody for up to 17 days against radiolytic decomposition.
Kaushik Dave, Shubh Sharma
Filed: 28 Jun 19
Utility
Infusion administration of conjugated monoclonal antibodies
10 Aug 20
A patient specific therapeutic composition provided in a single dose container, the total volume of which may be administered to a patient in a single treatment session.
Kaushik J. Dave, Yulian Zhang
Filed: 19 May 16
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first